Stock Detail
MYLAN INC
Drugs - Generic
MYL @ Yahoo Finance | MYL Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $18.17 | $18.64 | $-0.53 | -2.83% | 0.00 | $18.70 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $18.45 | $18.14 | 4.12M | 7.75B | 7.38M | 19.63 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 18.82 | 18.50 | 18.32 | 18.00 | 17.82 |
Stock Profile
Mylan Laboratories, Inc. engages in the development, licensing, manufacture, marketing, and distribution of generic and brand pharmaceutical products in the United States. Its Generic segment's pharmaceutical products are therapeutically equivalent to a brand name product and are marketed primarily to wholesalers, retail pharmacy chains, mail order pharmacies, and group purchasing organizations. These products are approved for distribution by the U.S. Food and Drug Administration (FDA) through the Abbreviated New Drug Application process. The company's Brand segment's pharmaceutical products are patent-protected products principally in the therapeutic areas of neurology, dermatology, and cardiology, which are approved by the U.S. FDA through the New Drug Application process. It also includes off-patent brand products, as well as branded generics. This segment markets its products directly to primary care physicians, dermatologists, neurologists, pharmacists, managed care organizations, governmental agencies, independent pharmacies, and chain drug stores. The company was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.